Recruiting Lupus Studies in Menifee
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of mo...
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of moderately to severely active SLE....
About Lupus Clinical Trials in Menifee
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Menifee, CA. These studies are seeking a combined 800 participants. Research is being sponsored by UCB Biopharma SRL, RemeGen Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Menifee — FAQ
Are there lupus clinical trials in Menifee?
Yes, there are 2 lupus clinical trials currently recruiting in Menifee, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Menifee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Menifee research site will contact you about next steps.
Are clinical trials in Menifee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Menifee studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Menifee are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov